REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioxcellerator S.A.S. (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Bioxcellerator S.A.S. Profile Updated: April 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bioxcellerator S.A.S. is an enterprise in Colombia, with the main office in Medellin. It operates in the General Medical and Surgical Hospitals sector. It was established on April 26, 2017. 54 (2024) employees currently work for Bioxcellerator S.A.S.. From the latest financial highlights, Bioxcellerator S.A.S. reported a net sales revenue increase of 31.83% in 2023. There was a total negative growth of 23.17% in Bioxcellerator S.A.S.’s total assets over the same period. In, 2023, the company’s net profit margin decreased by 17.29%.

Headquarters
Carrera 25 A 1 A Sur 45 Torre Medica 2 Ofi 944 Interior 1
Medellin; Antioquia;

Contact Details: Purchase the Bioxcellerator S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Bioxcellerator S.A.S. report to view the information.
Outstanding Shares:
Purchase the Bioxcellerator S.A.S. report to view the information.
Incorporation Date:
April 26, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Bioxcellerator S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.83%
Total operating revenue
31.83%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-1472.9%
Total assets
-23.17%
Total equity
-42.41%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-17.29%
Return on Equity (ROE)
27.09%
Quick Ratio
-1.53%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?